A First-in-Human, Phase 1 Study of Dsp- 9599, a Novel Direct Renin Inhibitor, with Translational Assessment in High-Renin Monkey

Trial Profile

A First-in-Human, Phase 1 Study of Dsp- 9599, a Novel Direct Renin Inhibitor, with Translational Assessment in High-Renin Monkey

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jul 2013

At a glance

  • Drugs DSP 9599 (Primary) ; Aliskiren
  • Indications Hypertension
  • Focus Adverse reactions
  • Most Recent Events

    • 08 Jul 2013 New trial record
    • 15 Jun 2013 Results presented at the 23rd European Meeting on Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top